BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6689424)

  • 1. The treatment of stage IIIA Hodgkin's disease.
    Lister TA; Dorreen MS; Faux M; Jones AE; Wrigley PF
    J Clin Oncol; 1983 Dec; 1(12):745-9. PubMed ID: 6689424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
    Crowther D; Wagstaff J; Deakin D; Todd I; Wilkinson P; Anderson H; Blackledge G; Jones M; Scarffe JH
    J Clin Oncol; 1984 Aug; 2(8):892-7. PubMed ID: 6379122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
    Anderson H; Crowther D; Deakin DP; Ryder WD; Radford JA
    Ann Oncol; 1991 Feb; 2 Suppl 2():49-54. PubMed ID: 2049321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
    Anderson H; Deakin DP; Wagstaff J; Jones JM; Todd ID; Wilkinson PM; James RD; Steward WP; Blackledge G; Scarffe JH
    Br J Cancer; 1984 Jun; 49(6):695-702. PubMed ID: 6375711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
    Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
    NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease.
    Harding MJ; McNulty LJ; Paul J; Lee F; Brown A; Soukop M
    Eur J Cancer; 1991; 27(8):1002-6. PubMed ID: 1832882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years.
    Dorreen MS; Wrigley PF; Laidlow JM; Plowman PN; Neudachin L; Tucker AK; Malpas JS; Stansfeld AG; Faux MM; Jones AE
    Cancer; 1984 Dec; 54(12):2882-8. PubMed ID: 6548658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children: long-term results.
    Armata J; Borkowski W; Depowska T
    Am J Pediatr Hematol Oncol; 1984; 6(4):462-5. PubMed ID: 6549497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of treatment of Hodgkin's disease in children. Observation of 203 cases treated with modified MVPP regimen combined with local radiotherapy].
    Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Radwańska U; Kaczmarek M; Ochocka M; Stańczak E; Sońta-Jakimczyk D; Sroczyńska M
    Pol Tyg Lek; 1990 Dec 17-31; 45(51-52):1037-41. PubMed ID: 2098742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with "minimal" stage IIIA Hodgkin's disease.
    Powlis WD; Mauch P; Goffman T; Goodman RL
    Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1437-42. PubMed ID: 3305442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment selection for stage IIIA Hodgkin's disease patients.
    Prosnitz LR; Cooper D; Cox EB; Kapp DS; Farber LR
    Int J Radiat Oncol Biol Phys; 1985 Aug; 11(8):1431-7. PubMed ID: 3894302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.
    Ranson MR; Radford JA; Swindell R; Deakin DP; Wilkinson PM; Harris M; Johnson RJ; Crowther D
    Ann Oncol; 1991 Jun; 2(6):423-9. PubMed ID: 1768629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
    Radford JA; Crowther D; Rohatiner AZ; Ryder WD; Gupta RK; Oza A; Deakin DP; Arnott S; Wilkinson PM; James RD
    J Clin Oncol; 1995 Sep; 13(9):2379-85. PubMed ID: 7666097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tirelli U; Bortolus R; van 't Veer MB; Lybeert ML; Keuning JJ; Carde P; Girinsky T; van der Maazen RW; Tomsic R; Vovk M; van Hoof A; Demeestere G; Lugtenburg PJ; Thomas J; Schroyens W; De Boeck K; Baars JW; Kluin-Nelemans JC; Carrie C; Aoudjhane M; Bron D; Eghbali H; Smit WG; Meerwaldt JH; Hagenbeek A; Pinna A; Henry-Amar M;
    N Engl J Med; 2003 Jun; 348(24):2396-406. PubMed ID: 12802025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.
    Mauch P; Goffman T; Rosenthal DS; Canellos GP; Come SE; Hellman S
    J Clin Oncol; 1985 Sep; 3(9):1166-73. PubMed ID: 3839844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.
    Green JA; Dawson AA; Fell LF; Murray S
    Br J Clin Pharmacol; 1980 May; 9(5):511-4. PubMed ID: 6893156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
    Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
    J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.